Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFκB, cyclinD and MMP-1 transcription

Phytomedicine

Volumn 16, Issue 10, 2009, Pages 916-922

  Liu, Q ^a   Loo, Wings T Y ^a   Sze, S C W ^a   Tong, Y ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Curcuma longa; Curcumin; CyclinD1 CDK4; MMPs; NF B

Indexed keywords

CELL CYCLE PROTEIN; CURCUMIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MESSENGER RNA; STROMELYSIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMA; CURCUMIN; CYCLIN D; CYCLIN-DEPENDENT KINASE 4; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 1; NF-KAPPA B; P21-ACTIVATED KINASES; PHYTOTHERAPY; PLANT EXTRACTS;

CURCUMA LONGA;

EID: 69849091814     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.04.008     Document Type: Article

References (18)

1. Agresti A., and Bianchi M.E. HMGB proteins and gene expression. Curr. Opin. Genet. Dev. 13 (2003) 170-178
2. Buckley M.F., Sweeney K.J., Hamilton J.A., Sini R.L., Manning D.L., Nicholson R.I., deFazio A., Watts C.K., Musgrove E.A., and Sutherland R.L. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8 (1993) 2127-2133
3. Choudhuri T., Pal S., Das T., and Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem. 280 (2005) 20059-20068
4. Coulonval K., Bockstaele L., Paternot S., Dumont J.E., and Roger P.P. The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis. Exp. Cell Res. 291 (2003) 135-149
5. Fisher D.E. Apoptosis in cancer therapy: crossing the threshold. Cell 78 (1994) 539-542
6. Garcia-Morales P., Hernando E., Carrasco-Garcia E., Menendez-Gutierrez M.P., Saceda M., and Martinez-Lacaci I. Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells. Mol. Cancer Ther. 5 (2006) 2172-2181
7. Giambernardi T.A., Grant G.M., Taylor G.P., Hay R.J., Maher V.M., McCormick J.J., and Klebe R.J. Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol. 16 (1998) 483-496
8. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., and Baldwin Jr. A.S. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell Biol. 19 (1999) 5785-5799
9. Haefner B. NF-kappa B: arresting a major culprit in cancer. Drug Discov. Today 7 (2002) 653-663
10. Hall M., and Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68 (1996) 67-108
11. Kaufmann S.H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49 (1989) 5870-5878
12. Mengshol J.A., Vincenti M.P., Coon C.I., Barchowsky A., and Brinckerhoff C.E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 43 (2000) 801-811
13. Nakshatri H., Bhat-Nakshatri P., Martin D.A., Goulet Jr. R.J., and Sledge Jr. G.W. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol. Cell Biol. 17 (1997) 3629-3639
14. Rochefort H., Glondu M., Sahla M.E., Platet N., and Garcia M. How to target estrogen receptor-negative breast cancer?. Endocr.-Relat. Cancer 10 (2003) 261-266
15. Shao Z.M., Shen Z.Z., Liu C.H., Sartippour M.R., Go V.L., Heber D., and Nguyen M. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int. J. Cancer 98 (2002) 234-240
16. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
17. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9 (1995) 1149-1163
18. Wong S.C., Chan J.K., Lee K.C., and Hsiao W.L. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. J. Pathol. 194 (2001) 35-42